Pricing

Log inSign up

Ashvattha Therapeutics

21 people · 0 jobs
‌

Ashvattha Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel hydroxyl dendrimer (HD) therapeutics (HDTs) to treat unmet medical needs in oncology, ophthalmology, and inflammatory diseases.

Industries

Biotechnology

Headquarters

Redwood City, United States

Employees

11-50

Links

Org chart

Jeffrey L. Cleland
Chairman, President & CEO
Collapse
SM
S. Sakura Minami
VP Translational Medicine And Nonclinical Development

Board & advisors

Kannan Rangaramanujam
Co-Founder & Chair, Scientific Advisory Board
BS
Barbara Slusher
Director
GM
George Montgomery
Director
Jay Zaveri
Director
YZ
Yuhang Zhao
Director
NP
Nicholas A. Peppas
Scientific Advisor
HG
Hamid Ghandehari
Scientific Advisor
KG
Kim Green
Scientific Advisor
SM
Samir Mitragotri
Scientific Advisor
GS
G. Mani Subramanian
Scientific Advisor

Teams

NM
+1

Scientific Teams

5 people · 0 jobs

HG
KG
NP
+2

Scientific Advisory Team

6 people · 0 jobs

Leadership Team

1 person · 0 jobs

Offices

Similar companies

Tango Therapeutics

3 followers

Cellares

4 followers

Gilead Sciences

163 followers

Regeneron

135 followers

Illumina

79 followers

Agilent Technologies

85 followers

Verily Life Sciences

46 followers

Alexion Pharmaceuticals

45 followers

GRAIL

30 followers

Cytiva

19 followers

PerkinElmer

12 followers

Explore companies